ORATORIO · WA25046
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis. 2010-020338-25 ( EudraCT Number )
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology